Determination of prognostic factors in 18F-FDG PET/CT of relapsed/refractory Hodgkin lymphoma

被引：0
|
作者：
Jajroudi, M. [1 ]
Geramifar, P. [2 ]
Eslami, S. [1 ,3 ]
机构：
[1] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Med Informat, Mashhad, Iran
[2] Univ Tehran Med Sci, Res Ctr Nucl Med, Nucl Med, Tehran, Iran
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Med Informat, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-2121
引用
收藏
页码：S1908 / S1909
页数：2
相关论文
共 50 条
  • [41] Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma
    Domenico Albano
    Giovanni Bosio
    Chiara Pagani
    Alessandro Re
    Alessandra Tucci
    Raffaele Giubbini
    Francesco Bertagna
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 87 - 96
  • [42] Prognostic value of metabolic criteria with 18F-FDG PET / CT in patients with follicular lymphoma
    Cozar Santiago, M.
    Garcia Garzon, J.
    Soler Peter, M.
    Igua Saenz, C.
    Sanz Llorens, R.
    Sanchez-Jurado, R.
    Aguilar Barrios, J.
    Faus Rodrigo, V.
    Riera Gil, E.
    Ferrer Rebolleda, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S724 - S725
  • [43] Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma
    Albano, Domenico
    Bosio, Giovanni
    Pagani, Chiara
    Re, Alessandro
    Tucci, Alessandra
    Giubbini, Raffaele
    Bertagna, Francesco
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) : 87 - 96
  • [44] THE PROGNOSTIC IMPACT OF 18F-FDG PET/CT IN LYMPHOMA PATIENTS AFTER STANDARD CHEMOTHERAPY
    Mladenov, K.
    Spassov, B.
    Hadzhiyska, V.
    Vassileva, D.
    HAEMATOLOGICA, 2017, 102 : 746 - 746
  • [45] 18f-FDG PET-CT Assessment of Responses to Salvage Therapy and Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)
    Tatarczuch, Maciej
    Hildyard, Catherine
    Subesinghe, Manil
    Eyre, Toby A.
    Collins, Graham
    BLOOD, 2017, 130
  • [46] Prognostic value of 18F-FDG PET/CT based on IMPeTUs in patients with relapsed multiple myeloma
    Guo, Yuehong
    Huang, Jingwei
    Wang, Li
    Liu, Aijun
    Yang, Min-Fu
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [47] The role of 18F-FDG PET/CT in the change of staging and therapeutic management in patients with Hodgkin Lymphoma
    Asabella, A. Niccoli
    Montemurro, I.
    Pisciotta, N.
    Rubini, D.
    Lauriero, F.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 241 - 241
  • [48] 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract
    Tempescul, Adrian
    Querellou, Solene
    Ianotto, Jean-Christophe
    Boisrame, Sylvie
    Valette, Gerald
    Berthou, Christian
    ANNALS OF HEMATOLOGY, 2010, 89 (06) : 635 - 637
  • [49] PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma
    Jauhari, Shekeab
    Nasta, Sunita D.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (09) : 8 - 13
  • [50] 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract
    Adrian Tempescul
    Solene Querellou
    Jean-Christophe Ianotto
    Sylvie Boisramé
    Gerald Valette
    Christian Berthou
    Annals of Hematology, 2010, 89 : 635 - 637
12345